Month: October 2021

Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to regulatory, clinical and public health concerns. We undertook a self-controlled case series study to investigate hospital admissions from neurological complications in the 28 days after a first dose of ChAdOx1nCoV-19 (n = 20,417,752) or BNT162b2 (n = 12,134,782), and after a SARS-CoV-2-positive test (n = 2,005,280). There […] Read More

Getting the right care, treatment and support at the right time can make a life-changing difference when you have a neurological condition, like GBS or CIDP. But there are huge variations across the UK – not everyone with a neurological condition in the UK has access to the same high quality, joined up care and […] Read More

Read the latest NHS guidance on vaccinations this winter: https://www.nhs.uk/conditions/vaccinations/flu-influenza-vaccine/

Rev Neurol. 2021 Oct 16;73(8):275-281. doi: 10.33588/rn.7308.2021261. ABSTRACT INTRODUCTION: Patients with CIDP respond adequately to steroid therapy and intravenous immunoglobulin (IVIG). However, few patients have access to IVIG in developing countries. Little information exists about the clinical response to steroid therapy in Latin American countries. OBJECTIVE: to describe the long-term functional clinical response (24 months) […] Read More

The public are being reminded to come forward for their flu jab to maximise their protection ahead of winter. Health officials are worried because this will be the first winter Covid and flu circulate fully at the same time. Research shows those infected with both viruses are more than twice as likely to die as […] Read More